Convenient route to Fmoc-homotyrosine via metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptides
- Org Biomol Chem. 2023 Nov 22;21(45):9011-9020. doi: 10.1039/d3ob01608k.
- 1. Faculté de Pharmacie, Université Laval, Québec, Québec, Canada, G1 V 0A6. [email protected].
- 2. Laboratory of Medicinal Chemistry, Centre de Recherche du CHU de Québec-Université Laval, 2705 Boulevard Laurier, Québec, Québec, Canada, G1 V 0A6.
- 3. Département de Biologie, Chimie et Géographie, Université du Québec à Rimouski, 300 allée des Ursulines, Rimouski, Québec, Canada, G5L 3A1.
Herein, we report the first solid-phase total synthesis of the natural cyclic peptide anabaenopeptin F and the use of metallaphotoredox catalysis to overcome the key challenges associated with the preparation of the non-proteinogenic amino acid homotyrosine contained in these peptides. Starting from L-homoserine, enantiopure Fmoc-protected homotyrosine was prepared in a straightforward manner by metallaphotoredox catalysis with N-Fmoc-(S)-2-amino-4-bromobutanoic acid and 4-tert-butoxybromobenzene partners. The prepared protected amino acid was used in solid-phase peptide synthesis to achieve the total synthesis of anabaenopeptin F and establish the stereochemistry of the isoleucine residue. Protease inhibition studies with the synthesized anabaenopeptin F showed inhibitory activities against Carboxypeptidase B in the low nanomolar range. The high convergency of the synthetic methodologies paves the way for the rapid access to N-Fmoc-protected non-proteinogenic and unnatural Amino acids and the total synthesis of complex bioactive peptides containing these Amino acids.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Drug DerivativeResearch Areas: Others